Cargando…
Abstract 10 Interim Results of a Phase I Study Investigating a Cord Blood-Derived Natural Killer Cell Therapy for Patients Hospitalized with COVID-19
INTRODUCTION: In the setting of viral infections, including infection with SARS-CoV-2, lymphocyte exhaustion and lymphopenia are common. Patients with COVID-19 who develop lymphopenia, particularly low numbers of circulating natural killer (NK) cells, are at high risk for disease progression. Thus,...
Autores principales: | Tercero, Almudena, Finlay, Dan, Asghedom, Liya H, Romasanta, Gladys R, Rice, Natalie T, Ranjbaran, Fatima, Stoltzman, Carrie, Cook, Jody, Blake, Joe, Delaney, Colleen, Hill, Joshua A |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Oxford University Press
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9446918/ http://dx.doi.org/10.1093/stcltm/szac057.010 |
Ejemplares similares
-
Abstract 9 Hematopoietic Stem Cell Transplantation (HSCT) with Omidubicel Leads to Robust Recovery and Diversity of T Cells
por: Szabolcs, Paul, et al.
Publicado: (2022) -
Abstract 3 Efficacy of Foscarnet in Preventing HHV6 Encephalitis in Adult Single Cord Blood Transplantation
por: Suzuki, Kotaro, et al.
Publicado: (2023) -
Abstract 1 Clinical and Imaging Outcomes After Allogenic Umbilical Cord Blood Transfusions in a Young Adult with Cerebral Palsy
por: Tseng, Sung Hui, et al.
Publicado: (2023) -
Abstract 2 Results of an Open Label Expanded Access Study of Omidubicel-onlv for Allogeneic Transplantation (allo-HCT) in Patients with Hematologic Malignancies
por: Horwitz, Mitchell, et al.
Publicado: (2023) -
Abstract 7 Reduced Intensity Conditioning Umbilical Cord Blood Transplantation in Combination with Splenic Irradiation in a Patient with Secondary Myelofibrosis and Massive Splenomegaly
por: Kaabneh, Basil, et al.
Publicado: (2022)